Nektar Therapeutics reported $0 in Debt for its fiscal quarter ending in June of 2022.





Debt Change Date
Agios Pharmaceuticals USD 31.17M 4.57M Jun/2026
ALKERMES USD 1.57B 10.58M Sep/2026
Alterity Therapeutics Limited AUD 210.39K 120.67K Jun/2023
Amgen USD 57.3B 19M Jun/2026
Baxter International USD 9.67B 20M Jun/2026
BioCryst Pharmaceuticals USD 828.6M 510K Dec/2024
Biogen USD 7.69B 398.3M Sep/2026
Bristol-Myers Squibb USD 42.88B 2.18B Sep/2026
Cara Therapeutics USD 0 0 Mar/2025
Cipla INR 6.99B 857M Sep/2026
Dr.Reddys Laboratories INR 71.95B 5.39B Jun/2026
Eisai JPY 254.94B 68.86B Sep/2026
Eli Lilly USD 54.91B 11.54B Jun/2026
Exelixis USD 162.2M 3.73M Sep/2026
Gilead Sciences USD 26.25B 4.07B Jun/2026
GlaxoSmithKline GBP 18.24B 818M Jun/2026
Grifols EUR 9.23B 626.05M Dec/2024
Halozyme Therapeutics USD 2.15B 2.02M Jun/2026
Incyte USD 38.27M 1.16M Jun/2026
Ionis Pharmaceuticals USD 1.77B 141M Sep/2026
Ironwood Pharmaceuticals USD 583.99M 14.83M Dec/2024
Karyopharm Therapeutics USD 299.23M 35.14M Dec/2025
MacroGenics USD 35.09M 1.42M Jun/2026
Merck USD 53.91B 4.79B Jun/2026
Nektar Therapeutics USD 0 0 Jun/2022
Neurocrine Biosciences USD 392.3M 9.5M Sep/2026
Novartis USD 49.01B 2.02B Jun/2026
Pfizer USD 62.67B 523M Sep/2026
Roche Holding CHF 33.03B 1.41B Jun/2025
Sarepta Therapeutics USD 857.36M 188.48M Sep/2026
Takeda JPY 4.58T 364.32B Sep/2026
Teva Pharmaceutical Industries USD 16.98B 110M Sep/2026
Xencor USD 170.11M 5.06M Jun/2026